Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets

Julian S. Rechberger, Cody L. Nesvick, David J. Daniels

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)187-192
Number of pages6
JournalExpert opinion on therapeutic targets
Volume26
Issue number3
DOIs
StatePublished - 2022

Keywords

  • ATRT
  • Atypical teratoid rhabdoid tumor
  • BAF
  • enhancer
  • epigenomics
  • rhabdoid tumor
  • SMARCB1
  • SWI/SNF
  • targeted therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this